University of Kentucky — Biomedical Watch V2

Essais liés20clinical trials

VilleLexingtonlocalisation

PaysUnited Stateslocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05617014

Ouvrir le site du centre

Essais cliniques associés

Molécule	Indication / population	Phase	NCT	Titre	Statut
Lab Assay for seven genetic variants for Parkinson's Disease	Parkinson	À vérifier	NCT04994015	Parkinson's Foundation PD GENEration Genetic Registry	RECRUITING
Low Dose Benfotiamine	Alzheimer	Phase 2	NCT06223360	A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)	ACTIVE_NOT_RECRUITING
rapcabtagene autoleucel	Lupus	Phase 2	NCT06581198	A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)	ACTIVE_NOT_RECRUITING
T2:C100	Alzheimer	Phase 2	NCT05644262	LiBBY — Life's End Benefits of cannaBidiol and tetrahYdrocannabinol	COMPLETED
NEU-411	Parkinson	Phase 2	NCT06680830	NEULARK — A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease	RECRUITING
Peripheral Nerve Tissue Implantation	Parkinson	Phase 1	NCT05377281	Feasibility and Safety of autoloGous UncondItioneD pEripheral Nerve Tissue Delivery to the Substantia Nigra (GUIDE)	ACTIVE_NOT_RECRUITING
Sural Nerve Graft to the Substantia Nigra	Parkinson	Phase 1	NCT06683365	LEAP — Autologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies	RECRUITING
Reparative Autologous peripheral nerve tissue	Parkinson	Phase 1	NCT06683378	STAR — A Study to Evaluate Feasibility, Safety, and Clinical Responses of Implanting Autologous Peripheral Nerve Tissue Into the Brain for Non-motor or Motor Symptoms in Patients With Parkinson's Disease Undergoing DBS Surgery	RECRUITING
Autologous Peripheral Nerve Graft	Parkinson	Phase 1	NCT02369003	CAPNG — Cont. of a Study to Evaluate Implanting Peripheral Nerve Grafts Into Subjects With Parkinson's Disease (PD) During DBS	ACTIVE_NOT_RECRUITING
Solanezumab	Alzheimer	Phase 3	NCT02008357	A4 — Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss	COMPLETED
AIDP — Automated Imaging Differentiation of Parkinsonism	Parkinson	À vérifier	NCT05913687	AIDP — Automated Imaging Differentiation of Parkinsonism	ACTIVE_NOT_RECRUITING
Neuraceq	Alzheimer	À vérifier	NCT05617014	ADNI4 — Alzheimer's Disease Neuroimaging Initiative 4	ENROLLING_BY_INVITATION
Telitacicept	Myasthénie	Phase 3	NCT06456580	A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)	RECRUITING
Eptinezumab	Migraine	Phase 3	NCT05164172	REJOIN — A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine	RECRUITING
BIA 28-6156	Parkinson	À vérifier	NCT07522606	Compassionate Use for BIA 28-6156 in Patients With Parkinson's Disease (PD) Who Have a Pathogenic Variant in the GBA1 Gene (GBA-PD) and Completed the ACTIVATE Study	NO_LONGER_AVAILABLE
Anti-hypertensive therapy	Hypertension	Phase 4	NCT02299414	Chronic Hypertension and Pregnancy (CHAP) Project	COMPLETED
Memantine	Sclérose latérale amyotrophique	Phase 2	NCT02118727	Therapy in Amyotrophic Lateral Sclerosis (TAME)	COMPLETED
APL-130277	Parkinson	Phase 3	NCT02542696	Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease	COMPLETED
ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand Opportunity	Alzheimer	À vérifier	NCT01078636	ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand Opportunity	COMPLETED
Zilucoplan	Sclérose latérale amyotrophique	Phase 2/3	NCT04297683	HEALEY ALS Platform Trial - Master Protocol	ACTIVE_NOT_RECRUITING